Beatrice is an elderly patient with multiple chronic conditions, including arthritic pain.

MEET BEATRICE

  • Age: 75
  • Condition: Beatrice has multiple chronic conditions including chronic obstructive pulmonary disease (COPD), osteoarthritis and dementia. She has also suffered from chronic arthritic pain for many years.
  • Treatment plan: Beatrice takes oxycocet 5/325 mg as needed to help manage her chronic pain. She also takes diazepam as needed for insomnia and multiple other medications for her COPD and dementia.
  • Other: Beatrice has seven grandchildren ranging from ages 2 to 11.

 

References: 1. American Addiction Centers. Opioid epidemic coming for the elderly. Available at: https://drugabuse.com/opioids/prescription/elderly-opioid-epidemic/. 2. Antoniou T, Pritlove C, Shearer D, et al. A qualitative study of a publicly funded pharmacy-dispensed naloxone program. International Journal of Drug Policy. 2021:103146. 3. Canadian Institute for Health Information. Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada. Available at: https://secure.cihi.ca/free_products/Opioid%20Poisoning%20Report%20%20EN.pdf. 4. Drug Free Kids Canada. Help your teens before they help themselves. Available at: https://www.drugfreekidscanada.org/prevention/drug-info/prescription-drugs/. 5. Finkelstein Y, Macdonald EM, Gonzalez A, et al. Overdose risk in young children of women prescribed opioids. Pediatrics. 2017;139(3):e20162887. 6. Government of Canada. Opioid overdose. Available at: https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/overdose.html. 7. Makris UE, Higashi RT, Marks EG, et al. Ageism, negative attitudes, and competing co-morbidities – why older adults may not seek care for restricting back pain: a qualitative study. Geriatrics. 2015;15:39. 8. Mueller SR et al. Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. Gen Intern Med. 2016;32(3):277-283. 9. Tsuyuki R et al. Canadian national consensus guidelines for naloxone prescribing by pharmacists. Canadian Pharmacists Journal. 2020;153(6):347-351.

PP-NAR4-CA-00087_05-2024 EN

Distributed by Emergent BioSolutions Canada Inc. Mississauga, ON L5N 6M1.

© 2025 Emergent BioSolutions Canada Inc., a wholly owned subsidiary of Emergent BioSolutions Inc.
NARCAN® is a registered trademark of Emergent Operations Ireland Limited, which is a subsidiary of Emergent BioSolutions Inc.

EMERGENT® and any and all Emergent BioSolutions Inc. brands, products, services and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its
subsidiaries in the United States or other countries.